Keywords: breast cancer; cutaneous metastasis; scar metastasis; HER2; human epidermal growth factor receptor 2;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HER2; AFP; Gastric cancer; Chemotherapy;
Keywords: Male breast cancer; ER; HER2; AR; Molecular profile; Genetics; Epigenetics; Prognosis;
Keywords: Immunohistochemistry; Genomic testing; Breast cancer; HER2; Hormone receptor status; RT-qPCR; RNA;
Keywords: Tumor budding; Breast cancer; Hormone receptors; Her2;
Keywords: LV; left ventricle; GLS; global longitudinal strain; CMR; cardiac magnetic resonance; LVEF; left ventricular ejection fraction; ECOG; Eastern Cooperative Oncology Group; HER2; human epidermal growth factor receptor 2; NYHA; New York Heart Association; Nt-
Keywords: NACT; neoadjuvant chemotherapy; pCR; complete pathological response; HER2; human epidermalgrowth factor receptor-2; NCCN; National Comprehensive Cancer Network; LABC; locally advanced breast cancer; M&P; Miller&Payne; DCIS; ductal carcinoma in situ; ER; e
Keywords: ER; estrogen receptor; HER2; human epidermal growth factor receptor 2; MP; MammaPrint; MSP; multigene signature panel; ODX; Oncotype DX;
Keywords: BMs; bone metastases; BPI; Brief Pain Inventory; BTA; bone-targeted agent; CI; confidence interval; DSP; Disease Specific Programme; EQ-5D; 5-dimension (3-level) EuroQol questionnaire; ER; estrogen receptor; FACT-B; Functional Assessment of Cancer Therapy
Keywords: cardio-oncology; cardiotoxicity; echocardiography; 2D; 2-dimensional; ASCO; American Society of Clinical Oncology; ASE; American Society of Echocardiography; CTRCD; cancer therapy-related cardiac dysfunction; EACVI; European Association of Cardiovascula
Keywords: MW; molecular weight; MDR1; multiple drug resistance 1; P-gp; P-glycoprotein; ABC-transporter; ATP-binding cassette transporter; ATP; adenosine triphosphate; BBB; blood brain barrier; SLC transporter; solute carrier transporter; logP; partition coefficien
Keywords: APC; antigen presenting cell; APOBEC; apolipoprotein B mRNA editing enzyme catalytic polypeptide-like; BRCA1/2; breast cancer 1/2; BCSS; breast cancer specific survival; B2M; β-2-microglobulin; CAF; cancer associated fibroblast; CCL; chemokine ligand; CD
Keywords: Small molecules; biologics; adverse effects mouth; BP; Bisphosphonates; EGFR; Epidermal growth factor receptor; FDA; Food and Drug Administration; HER2; Human epidermal growth factor receptor 2; HNSCC; Head and neck squamous cell carcinoma; mAbs; Monoclon
Keywords: AP; activator protein-1; APC; adenomatous polyposis coli; ATM; ataxia-telangiectasia; BDNF-AS; brain-derived neurotrophic factor antisense; BIN1; bridging integrator 1; BMP6; bone morphogenetic protein 6; BRCA; breast cancer associated gene; CpG; cytosine
Keywords: PET; SPECT; CT; Radiotracers; HER2; HER3; Metastasis; Breast cancer;
Keywords: NSCLC; Non-Small Cell Lung Carcinoma; SCLC; Small Cell Lung Carcinoma; AC; Adenocarcinoma; LCT; Lung Carcinoid Tumor; LCC; Large Cell Carcinoma; CTC; Circulating Tumor Cells; UICC; The Union for International Cancer Control; CT; Computer-based Tomography;
Keywords: AI; aromatase inhibitor; ASCO; American Society of Clinical Oncology; CDK4/6; cyclin-dependent kinase 4/6; DCIS; ductal carcinoma in situ; DFS; disease-free survival; ER; estrogen receptor; FDA; Food and Drug Administration; HER2; human epidermal growth f
Keywords: MD; Mediterranean diet; HT; hydroxytyrosol; IUPAC; International Union of Pure and Applied Chemistry; ADME; absorption, distribution, metabolism and excretion processes; EVOO; extra virgin olive oil; HTA; HT acetate; Tyr; tyrosol; EFSA; European Food Safe
Keywords: 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: CDK; cyclin dependent kinase; CDK4/6; cyclin dependent kinase 4 and 6; cdc; cell division cycle; CDC25C; cell division cycle 25 homolog; Ser/Thr; serine/ threonine; kDa; kilodaltonsâ(molecular weight); Cip/Kip; CDK interacting protein/kinase inhibitory
Keywords: Colorectal cancer; Clinical trials; KRAS; BRAF; Her2; Immunotherapy;
Keywords: Peroxisome; Cancer; Pexophagy; Plasmalogen; Mitochondrion; Metabolism; AA; arachidonic acid; ABCD; ATP-binding cassette (ABC) transporters subfamily D; ACOX; Acyl Coenzyme-A oxidase; AGPS; alkyl-glycerone phosphate synthase; AMACR; α-Methylacyl-CoA racem
Keywords: AAV; adeno-associated viruses; ADA; adenosine deaminase deficiency; APCs; antigen presenting cells; AuNC; gold nanoclusters; AuNPs; gold nanoparticles; AuNRs; gold nanorods; BBB; blood-brain barrier; Bcl-2; B-cell lymphoma 2; Cas; CRISPR-associated; ChNPs
Keywords: ARV-825 PubChem CID 92044400; BETd-246 PubChem CID 131698640; dBET1 PubChem CID 91799313; I-BET151 PubChem CID 52912189; I-BET762 PubChem CID 46943432; JQ1 PubChem CID 46907787; MS417 PubChem CID 59190723; OTX015 PubChem CID 9936746; THZ1 PubChem CID 7360
Keywords: Breast cancer; Cannabidiol; Apoptosis; mTOR; Cyclin D1 and PPARγ; CBD; Cannabidiol; ER; Estrogen receptor; PR; Progesterone receptor; HER2; Human Epidermal Growth Factor Two; TNBC; Triple Negative Breast Cancer; IP; Immunoprecipitation; MTT; Methylthiazo
Keywords: Analysis; Database; HER2; Hormone; Surgery;
Keywords: cardio-oncology; cardiovascular magnetic resonance; tissue characterization; 2D; 2-dimensional; 3D; 3-dimensional; CMR; cardiovascular magnetic resonance; ECV; extracellular volume; GBCA; gadolinium-based contrast agent; GLS; global longitudinal strain;
Keywords: S. carnosus; Flow cytometry; Antibody; HER2; Phage display; Cell-surface display; Affinity maturation;
Keywords: BSGI; breast-specific gamma imaging; ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal growth factor receptor 2; CIS; carcinoma in situ; EIC; extensive intraductal component; Breast; Neoplasms; Radionuclide imaging; Mammography; Path
Keywords: 4-ABP; 4-aminobiphenyl; CI; confidence interval; CrI; credible interval; AA-Hb; acrylamide-hemoglobin; AcE; acetylcholinesterase; AhR; aryl hydrocarbon receptor; APFO; ammonium perfluorooctanoate; AR; androgen receptor; BBMP; 2,2-bis(bromomethyl)-1,3-prop
Keywords: Lymphangioleiomyomatosis; EGFR; HER2; HER3; HER4;
Keywords: DIA; digital image analysis; AI; artificial intelligence; H&E; hematoxylin and eosin; IHC; immunohistochemistry; ISH; in situ hybridization; DCIS; ductal carcinoma in situ; ER; estrogen receptor α; PR; progesterone receptor; HER2; human epidermal growth
Keywords: microRNA-331; Breast cancer; Breast benign tumors; Ductal adenocarcinoma; Lobular adenocarcinoma; Biomarker; ASCO; American Society of Clinical Oncologists; AUC; Area under the curve; CAP; College of American Pathologists; cDNA; Complementary DNA; DCIS; D
Keywords: ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal receptor 2; NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells; STAT; signal transducer and activator of transcription; CHM; Chinese herbal medicine; EMT; epitheli
Keywords: Immunohistochemistry; HER2; CD34; CD31; Vasculogenesis; Endothelial progenitor cells; Monocytes;
Keywords: Akt; protein kinase B; Bcl-2; B-cell lymphoma-2; Bax; Bcl-2 associated X protein; CDK; cyclin-dependent kinase; CRC; colorectal cancer; CI; combination index; Cyto c; cytochrome c; ECAR; extracellular acidification rate; EGFR; epidermal growth factor rece
Keywords: BRCA1/2; Breast cancer; Cancer stem cells; Estrogen receptors; HER2; Noncoding RNAs; Triple-negative breast cancer; Tumor heterogeneity;
Keywords: 5-Azacitidine (PubMED CID: 9444); 5-Fluorouracil (PubMED CID: 3385); Afatinib (PubMED CID: 10184653); Abemaciclib (PubMED CID: 46220502); Alisertib (PubMED CID: 24471867); Alpelisib (PubMED CID: 56649450); Anastrozole (PubMED CID: 2187); Apitolisib (PubME
Keywords: MDR; multi-drug resistance; PPI; polypropyleneimine; RBC; red blood cell; WBC; white blood cell; LDH; lactate dehydrogenase; EPR; enhances permeability and retention; FA; folic acid; FR; FA receptor; SMUT; sodium-dependent multi-vitamin transporter; FITC;
Keywords: 56MESS; (1S2S-diaminocyclohexane)platinum(II)] dichloride; AIBN; 2,2â²-azobisisobutyronitrile; Apt; aptamer; AUC; area under curve; BBR3464; (trans,trans,trans)-bis-mu-(hexane-16-diamine)-mu-[diammineplatinum(II)]bis[diammine(chloro)platinum(II)] tetrani
Keywords: Lacrimal gland; Carcinoma ex pleomorphic adenoma; Androgen receptor; HER2;
Keywords: IDC; invasive ductal carcinoma; IL-35; interleukin-35; Tregs; regulatory T cells; TILs; tumor-infiltrating lymphocytes; EBI3; Epstein-Barr Virus (EBV)-induced gene 3; Bregs; regulatory B cells; PFS; progression-free survival; OS; overall survival; ER; est
Keywords: Breast cancer; Caribbean; Incidence; Hormone receptors; Her2; Guadeloupe; Survival;
Keywords: Urothelial cancer; Angiogenesis; HER2; Targeted therapy;
Keywords: Monoclonal antibody therapy; ADCC; Trastuzumab; HER2; Tyrosine kinase inhibitors; LDH assay;
Keywords: Topoisomerase I; Topoisomerase IIα; HER2; Genomic profiling; Solid tumors;
Keywords: Breast cancer; Oestrogen receptor; HER2; Secular trends; Incidence rates;
Keywords: AJCC; American Joint Committee on Cancer; BNF; British National Formulary; CI; confidence interval; CPRD; Clinical Practice Research Datalink; ER; oestrogen receptor; GP; general practitioner; HR; hazard ratio; HER2; human epidermal growth factor receptor
Glyceollins: Soybean phytoalexins that exhibit a wide range of health-promoting effects
Keywords: 3T3-L1; mouse fibroblast cell line; 4CL; 4-coumarate:coenzyme A ligase; ABTS; 2,2â²-azinobis(3-ethylbenzthiazoline-6-sulfonate); ACC; acetyl-coA carboxylase; AKT; protein kinase B; AMPK; adenosine-monophosphate kinase; Ang-1; angiopoietin-1; BCRP; breast
Keywords: G17DT; CCK-B Receptor; Proton Pump Inhibitors; PPIs; CCK-BR; cholecystokinin-B receptor; ECL; enterochromaffin-like; EGFR; epidermal growth factor receptor; ERK; extracellular signal-regulated kinase; HER2; human epidermal growth factor receptor 2; IHC;